{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:25:28Z","timestamp":1760149528737,"version":"build-2065373602"},"reference-count":57,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Interdisciplinary Center of Clinical Research (IZKF) at the University of W\u00fcrzburg","award":["Z-2\/72_P"],"award-info":[{"award-number":["Z-2\/72_P"]}]},{"name":"German Cancer Consortium","award":["Z-2\/72_P"],"award-info":[{"award-number":["Z-2\/72_P"]}]},{"name":"University of W\u00fcrzburg","award":["Z-2\/72_P"],"award-info":[{"award-number":["Z-2\/72_P"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Vestibular schwannoma (VS) are benign cranial nerve sheath tumors of the vestibulocochlear nerve. Their incidence is mostly sporadic, but they can also be associated with NF2-related schwannomatosis (NF2), a hereditary tumor syndrome. Metastasis associated in colon cancer 1 (MACC1) is known to contribute to angiogenesis, cell growth, invasiveness, cell motility and metastasis of solid malignant cancers. In addition, MACC1 may be associated with nonsyndromic hearing impairment. Therefore, we evaluated whether MACC1 may be involved in the pathogenesis of VS. Sporadic VS, recurrent sporadic VS, NF2-associated VS, recurrent NF2-associated VS and healthy vestibular nerves were analyzed for MACC1 mRNA and protein expression by quantitative polymerase chain reaction and immunohistochemistry. MACC1 expression levels were correlated with the patients\u2019 clinical course and symptoms. MACC1 mRNA expression was significantly higher in sporadic VS compared to NF2-associated VS (p &lt; 0.001). The latter expressed similar MACC1 concentrations as healthy vestibular nerves. Recurrent tumors resembled the MACC1 expression of the primary tumors. MACC1 mRNA expression was significantly correlated with deafness in sporadic VS patients (p = 0.034). Therefore, MACC1 might be a new molecular marker involved in VS pathogenesis.<\/jats:p>","DOI":"10.3390\/cancers15164089","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T10:40:31Z","timestamp":1692009631000},"page":"4089","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness"],"prefix":"10.3390","volume":"15","author":[{"given":"Maria","family":"Breun","sequence":"first","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Flock","sequence":"additional","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-4854","authenticated-orcid":false,"given":"Jonas","family":"Feldheim","sequence":"additional","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"},{"name":"Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Nattmann","sequence":"additional","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"},{"name":"Department of Ophthalmology, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia M.","family":"Monoranu","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Department of Neuropathology, University of W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9-Universit\u00e4tsmedizin Berlin and Max-Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf-Ingo","family":"Ernestus","sequence":"additional","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"L\u00f6hr","sequence":"additional","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9759-8149","authenticated-orcid":false,"given":"Carsten","family":"Hagemann","sequence":"additional","affiliation":[{"name":"Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-282X","authenticated-orcid":false,"given":"Ulrike","family":"Stein","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Charit\u00e9-Universit\u00e4tsmedizin Berlin and Max-Delbr\u00fcck Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), 69120 Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.1889","article-title":"MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis","volume":"15","author":"Stein","year":"2009","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10555-018-9771-8","article-title":"MACC1\u2014The first decade of a key metastasis molecule from gene discovery to clinical translation","volume":"37","author":"Radhakrishnan","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/neuonc\/not136","article-title":"Impact of MACC1 on human malignant glioma progression and patients\u2019 unfavorable prognosis","volume":"15","author":"Hagemann","year":"2013","journal-title":"Neuro-Oncology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hagemann, C., Neuhaus, N., Dahlmann, M., Kessler, A.F., Kobelt, D., Herrmann, P., Eyrich, M., Freitag, B., Linsenmann, T., and Monoranu, C.M. (2019). Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response. Cancers, 11.","DOI":"10.3390\/cancers11060825"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000320154","article-title":"Novel Autosomal Recessive Nonsyndromic Hearing Impairment Locus DFNB90 Maps to 7p22.1-p15.3","volume":"71","author":"Ali","year":"2011","journal-title":"Hum. Hered."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/ol.2012.1011","article-title":"Clinical features of intracranial vestibular schwannomas","volume":"5","author":"Huang","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJMra2020394","article-title":"Vestibular Schwannomas","volume":"384","author":"Carlson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3171\/2010.4.JNS091962","article-title":"A prospective study of hearing preservation in untreated vestibular schwannomas","volume":"114","author":"Sughrue","year":"2011","journal-title":"J. Neurosurg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s40136-021-00341-x","article-title":"Management of Neurofibromatosis Type 2 Associated Vestibular Schwannomas","volume":"9","author":"Jia","year":"2021","journal-title":"Curr. Otorhinolaryngol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s40136-021-00337-7","article-title":"The Natural History of Vestibular Schwannoma and When to Intervene","volume":"9","author":"Tan","year":"2021","journal-title":"Curr. Otorhinolaryngol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sanchez, L.D., Bui, A., and Klesse, L.J. (2021). Targeted Therapies for the Neurofibromatoses. Cancers, 13.","DOI":"10.3390\/cancers13236032"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North West of England over a 10-year Period: Higher Incidence than Previously Thought","volume":"26","author":"Evans","year":"2005","journal-title":"Otol. Neurotol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awm249","article-title":"Magic but treatable? Tumours due to loss of Merlin","volume":"131","author":"Hanemann","year":"2008","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ctrv.2014.05.004","article-title":"Systemic therapy in neurofibromatosis type 2","volume":"40","author":"Lim","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-014-0082-1","article-title":"A neuronal function of the tumor suppressor protein merlin","volume":"2","author":"Schulz","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"731441","DOI":"10.3389\/fonc.2021.731441","article-title":"Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajhg.2009.06.003","article-title":"Noncoding Mutations of HGF Are Associated with Nonsyndromic Hearing Loss, DFNB39","volume":"85","author":"Schultz","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3892\/ijo.2013.1798","article-title":"Microarray analysis of gene expression in vestibular schwannomas reveals SPP1\/MET signaling pathway and androgen receptor deregulation","volume":"42","author":"Lassaletta","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/15384047.2014.972765","article-title":"Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells","volume":"16","author":"Dilwali","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2015.64.3817","article-title":"Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2\u2013Associated Vestibular Schwannomas","volume":"34","author":"Blakeley","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1535-7163.MCT-17-0417","article-title":"Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells","volume":"16","author":"Fuse","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E2077","DOI":"10.1073\/pnas.1719966115","article-title":"Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models","volume":"115","author":"Zhao","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jmg.2006.047753","article-title":"Mosaicism in neurofibromatosis type 2: An update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification","volume":"44","author":"Evans","year":"2007","journal-title":"J. Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","article-title":"Clinical and molecular predictors of mortality in neurofibromatosis 2: A UK national analysis of 1192 patients","volume":"52","author":"Hexter","year":"2015","journal-title":"J. Med. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103148","DOI":"10.1016\/j.amjoto.2021.103148","article-title":"Reliability and toxicity of bevacizumab for neurofibromatosis type 2-related vestibular schwannomas: A systematic review and meta-analysis","volume":"42","author":"Shi","year":"2021","journal-title":"Am. J. Otolaryngol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tamura, R., and Toda, M. (2022). A Critical Overview of Targeted Therapies for Vestibular Schwannoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105462"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/curroncol28010071","article-title":"Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma","volume":"28","author":"Fujii","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/neuonc\/noz153","article-title":"EANO guideline on the diagnosis and treatment of vestibular schwannoma","volume":"22","author":"Goldbrunner","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006123-199702000-00005","article-title":"Management of 1000 Vestibular Schwannomas (Acoustic Neuromas): Hearing Function in 1000 Tumor Resections","volume":"40","author":"Samii","year":"1997","journal-title":"Neurosurgery"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.wneu.2016.07.085","article-title":"When Does Hearing Loss Occur in Vestibular Schwannoma Surgery? Importance of Auditory Brainstem Response Changes in Early Postoperative Phase","volume":"95","author":"Hummel","year":"2016","journal-title":"World Neurosurg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/MAO.0b013e3182595454","article-title":"Growth Characteristics of Vestibular Schwannomas","volume":"33","author":"Moffat","year":"2012","journal-title":"Otol. Neurotol."},{"key":"ref_35","first-page":"1856","article-title":"ADAM9: A novel player in vestibular schwannoma pathogenesis","volume":"19","author":"Breun","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Feldheim, J., Kessler, A.F., Schmitt, D., Salvador, E., Monoranu, C.M., Feldheim, J.J., Ernestus, R.-I., L\u00f6hr, M., and Hagemann, C. (2020). Ribosomal Protein S27\/Metallopanstimulin-1 (RPS27) in Glioma\u2014A New Disease Biomarker?. Cancers, 12.","DOI":"10.3390\/cancers12051085"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 Years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.2147\/OTT.S176549","article-title":"Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients","volume":"11","author":"Feldheim","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2990.2006.00769.x","article-title":"Differential gene expression between human schwannoma and control Schwann cells","volume":"32","author":"Hanemann","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1038\/onc.2015.404","article-title":"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","article-title":"Molecular insights into NF2\/Merlin tumor suppressor function","volume":"588","author":"Cooper","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13277-014-2736-9","article-title":"MACC1 overexpression and survival in solid tumors: A meta-analysis","volume":"36","author":"Wang","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/0036554021000028075","article-title":"Hearing deterioration in patients with a non-growing vestibular schwannoma","volume":"123","author":"Graamans","year":"2003","journal-title":"Acta Oto-Laryngol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00129492-200403000-00012","article-title":"Hearing Changes after Diagnosis in Neurofibromatosis Type 2","volume":"25","author":"Masuda","year":"2004","journal-title":"Otol. Neurotol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Asthagiri, A.R., Vasquez, R.A., Butman, J.A., Wu, T., Morgan, K., Brewer, C.C., King, K., Zalewski, C., Kim, H.J., and Lonser, R.R. (2012). Mechanisms of Hearing Loss in Neurofibromatosis Type 2. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046132"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107770","DOI":"10.1016\/j.heares.2019.07.007","article-title":"NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss","volume":"381","author":"Sagers","year":"2019","journal-title":"Hear. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bommakanti, K., Seist, R., Kukutla, P., Cetinbas, M., Batts, S., Sadreyev, R.I., Stemmer-Rachamimov, A., Brenner, G.J., and Stankovic, K.M. (2023). Comparative Transcriptomic Analysis of Archival Human Vestibular Schwannoma Tissue from Patients with and without Tinnitus. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072642"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4049\/jimmunol.0900173","article-title":"Cutting Edge: TNF-\u03b1 Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation","volume":"183","author":"Franchi","year":"2009","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3389\/fimmu.2020.00980","article-title":"Pro-inflammatory TNF-\u03b1 and IFN-\u03b3 Promote Tumor Growth and Metastasis via Induction of MACC1","volume":"11","author":"Kobelt","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9940","DOI":"10.18632\/oncotarget.24119","article-title":"CXCR4: A new player in vestibular schwannoma pathogenesis","volume":"9","author":"Breun","year":"2018","journal-title":"Oncotarget"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DDDT.S280069","article-title":"A Review of Drug Therapy in Vestibular Schwannoma","volume":"15","author":"Long","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-016-1583-8","article-title":"The importance of nerve microenvironment for schwannoma development","volume":"132","author":"Schulz","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Nattmann, A., Breun, M., Monoranu, C.M., Matthies, C., Ernestus, R.-I., L\u00f6hr, M., and Hagemann, C. (2020). Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells. BMC Res. Notes, 13.","DOI":"10.1186\/s13104-020-05378-7"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Juneja, M., Kobelt, D., Walther, W., Voss, C., Smith, J., Specker, E., Neuenschwander, M., Gohlke, B.-O., Dahlmann, M., and Radetzki, S. (2017). Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1. PLOS Biol., 15.","DOI":"10.1371\/journal.pbio.2000784"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e726","DOI":"10.1002\/ctm2.726","article-title":"Real-world evidence for preventive effects of statins on cancer incidence: A trans-Atlantic analysis","volume":"12","author":"Gohlke","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0194599820937970","article-title":"Association of Metformin with the Growth of Vestibular Schwannomas","volume":"164","author":"Tran","year":"2021","journal-title":"Otolaryngol. Head Neck Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/16\/4089\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:33:19Z","timestamp":1760128399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/16\/4089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":57,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["cancers15164089"],"URL":"https:\/\/doi.org\/10.3390\/cancers15164089","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2023,8,14]]}}}